Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Link Between the Clinical Resting Heart Rate and Sympathetic Overactivation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02315313
Recruitment Status : Unknown
Verified December 2014 by Wang Jiguang, Ruijin Hospital.
Recruitment status was:  Not yet recruiting
First Posted : December 11, 2014
Last Update Posted : December 11, 2014
Sponsor:
Information provided by (Responsible Party):
Wang Jiguang, Ruijin Hospital

Brief Summary:
It is a retrospective study with no products limitation to investigate the link between clinical resting HR and SOA. Use HR≤60bpm as control group, compare other three groups with the control group and find out the correlation between HR and SOA indexes.

Condition or disease
Cardiovascular Disease

Layout table for study information
Study Type : Observational
Estimated Enrollment : 1000 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Study Start Date : December 2014
Estimated Primary Completion Date : December 2015

Group/Cohort
group1
RHR≤60bpm
group2
RHR 61-70bpm
group3
RHR 71-80bpm
group4
RHR >80bpm



Primary Outcome Measures :
  1. The difference of HRV, BPV, LF/HF between each groups [ Time Frame: 1min HR measure ]
    The difference on mean sympathetic overactivation related indexes such as HRV, BPV, LF/HF between groups



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
cardiovascular disease patient
Criteria

Inclusion Criteria:

  1. Provision of subject informed written or oral consent
  2. Female and male aged≥ 20 to ≤ 80 years;
  3. Records on mean clinical heart rate and SOA indexes were available.

Exclusion Criteria:

  1. Participation in another clinical study with an investigational product during the last 6 months;
  2. Drug intervention on heart rate 1 month prior to the inclusion;
  3. Patients with missing data in the database from the Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02315313


Contacts
Layout table for location contacts
Contact: Jiguang Wang, PHD 13764189476 wangjiguang2000@126.com

Sponsors and Collaborators
Ruijin Hospital

Layout table for additonal information
Responsible Party: Wang Jiguang, Director, The Shanghai Institute of Hypertension, Ruijin Hospital
ClinicalTrials.gov Identifier: NCT02315313     History of Changes
Other Study ID Numbers: ESR-14-10153
First Posted: December 11, 2014    Key Record Dates
Last Update Posted: December 11, 2014
Last Verified: December 2014

Additional relevant MeSH terms:
Layout table for MeSH terms
Cardiovascular Diseases